Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/1999
06/24/1999WO1998043668A9 Attenuated respiratory syncytial virus
06/24/1999DE19757301A1 Intra-nasal vaccine against yellow fever
06/24/1999CA2635158A1 Protein expression in baculovirus vector expression systems
06/24/1999CA2615701A1 Process for the preparation of 6-o-methyl erythromycin a using 9-hydroxy erythromycin derivatives
06/24/1999CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
06/24/1999CA2315370A1 Integrin receptor antagonists
06/24/1999CA2315256A1 Needle-free injection of formulated nucleic acid molecules
06/24/1999CA2315232A1 Integrin receptor antagonists
06/24/1999CA2314683A1 Therapeutic use of lentiviral vectors
06/24/1999CA2314431A1 Screening assays for the detection and diagnosis of influenza virus
06/24/1999CA2314422A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development
06/24/1999CA2314355A1 Use of pyrazolo ¢3,4-b! pyridine as cyclin dependent kinase inhibitors
06/24/1999CA2314335A1 Purine derivatives having phosphodiesterase iv inhibition activity
06/24/1999CA2314319A1 Novel surface protein of neisseria meningitidis
06/24/1999CA2314139A1 Cephalosporin antibiotics
06/24/1999CA2313212A1 Modulators of cysteine protease
06/24/1999CA2313004A1 3-substituted adenines via2-thioxanthines
06/24/1999CA2312940A1 Antipicornaviral compounds and methods for their use and preparation
06/23/1999EP0924298A1 Protein expression in baculovirus vector expression systems
06/23/1999EP0924295A2 DNA encoding neospora dihydrofolate reductase-thymidylate synthase
06/23/1999EP0924212A1 Chrolactomycin compound
06/23/1999EP0924210A1 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives
06/23/1999EP0923939A1 Methods and compositions for the treatment of infection and control of flora
06/23/1999EP0923594A1 Bromotiacumicin compounds
06/23/1999EP0923585A1 Phosphinate based inhibitors of matrix metalloproteases
06/23/1999EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives
06/23/1999EP0923564A1 Pharmaceutical compounds
06/23/1999EP0923563A1 1,4-heterocyclic metallprotease inhibitors
06/23/1999EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
06/23/1999EP0923377A1 Therapeutic uses for an aminosterol compound
06/23/1999EP0923375A2 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl heterocyclic compound
06/23/1999EP0923292A1 Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals
06/23/1999EP0814660B1 Topical antimicrobial agents
06/23/1999EP0636024B1 Potentiation of antimicrobial effects
06/23/1999EP0598816B1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines
06/23/1999CN1220603A Anti-viral compounds
06/23/1999CN1220601A Anti-viral compounds
06/23/1999CN1220263A Novel hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof
06/23/1999CN1220153A Traditional Chinese medicine for curing AIDS and its producing method
06/23/1999CN1043786C Method for preparing antibiotic compound
06/23/1999CN1043769C L-nucleosides for treatment of hepatitis B-virus and epstein-bar virus and its use
06/22/1999US5914400 Method and compositions for the synthesis of BCH-189 and related compounds
06/22/1999US5914395 Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells
06/22/1999US5914332 Retroviral protease inhibiting compounds
06/22/1999US5914260 Fish pancreatic disease virus
06/22/1999US5914250 Gene which codes for mutant antibiotic having isoleucine substituted at 4 position of amino acid sequence
06/22/1999US5914123 Food comprising transgenic plant material, ingestible for nutritional value, expressing recombinant immunogen derived from hepatitis virus
06/22/1999US5914118 Multi-layered drug containing film preparation having powder adhesive thereon
06/22/1999US5914114 Concensus peptide and amino acid sequences thereof; conjugated to a molecule that increases antigenicity; immunizing mammals against varying strains of enterotoxigenic escherichia coli; colonization factor antigens (cfa)
06/22/1999US5914113 Inactivated immunogens from avian pathogens, an adjuvant and a live chicken anemia virus
06/22/1999US5914109 Heterohybridomas producing human monoclonal antibodies to HIV-1
06/22/1999CA2256252A1 Chrolactomycin compound
06/22/1999CA2147893C Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis .beta. virus activity
06/19/1999WO1999032139A1 Improved interferon polymer conjugates
06/17/1999WO1999029870A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999WO1999029863A1 Human interferon-epsilon: a type i interferon
06/17/1999WO1999029843A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
06/17/1999WO1999029730A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna
06/17/1999WO1999029723A1 Recombinant nodavirus compositions and methods
06/17/1999WO1999029717A2 Postweaning multisystemic wasting syndrome virus from pigs
06/17/1999WO1999029716A1 Echinocandin derivatives, preparation method and application as anti-fungal agents
06/17/1999WO1999029712A1 Peptide-based gemini compounds
06/17/1999WO1999029694A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999WO1999029693A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
06/17/1999WO1999029688A1 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones
06/17/1999WO1999029669A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
06/17/1999WO1999029662A2 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
06/17/1999WO1999029350A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999WO1999029342A1 Vaccines containing attenuated bacteria
06/17/1999WO1999029340A1 An over-expressing homologous antigen vaccine and a method of making the same
06/17/1999WO1999029321A1 Inhibition of membrane-associated viral replication
06/17/1999WO1999029318A1 Antiviral compounds
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1999029312A1 Methods for treatment of neuro- and nephro-disorders and therapeutic toxicities using aminothiol compounds
06/17/1999WO1999029173A1 Composition useful for providing one-step surgical preparation and drape
06/17/1999WO1999017787A3 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/17/1999WO1999017742A3 Taste masked formulations
06/17/1999WO1999016460A3 Apolipoprotein e/growth factor complexes and methods of use
06/17/1999WO1999015548A3 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof
06/17/1999WO1999015198A3 Agents for combating bacterial meningitis
06/17/1999WO1999010292A3 Robustaflavone, intermediates and analogues and method for preparation thereof
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response
06/17/1999DE19754796A1 Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New-derived azacycloalkanes urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation
06/17/1999DE19754795A1 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation
06/17/1999CA2317806A1 An over-expressing homologous antigen vaccine and a method of making the same
06/17/1999CA2314408A1 Antiviral compounds
06/17/1999CA2313823A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999CA2313806A1 Postweaning multisystemic wasting syndrome virus from pigs
06/17/1999CA2313703A1 Vaccines containing attenuated bacteria
06/17/1999CA2313350A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna
06/17/1999CA2313150A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999CA2312941A1 Peptide-based gemini compounds
06/17/1999CA2312698A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999CA2312484A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
06/17/1999CA2312423A1 Inhibition of membrane-associated viral replication
06/17/1999CA2311681A1 Human interferon-epsilon: a type i interferon
06/17/1999CA2311295A1 Echinocandin derivatives, preparation method and application as anti-fungal agents
06/17/1999CA2309686A1 Composition useful for providing one-step surgical preparation and drape
06/17/1999CA2309388A1 New urethanes derived from azacycloalkanes, the thio and dithio analogues thereof, the salts thereof, pharmaceutical compositions containing these compounds and their use as well as processes for preparing them